Fujimoto M - Search Results

1

Elevation of serum lymphotactin levels in patients with systemic sclerosis.

Muroi E, Ogawa F, Shimizu K, Komura K, Hasegawa M, Fujimoto M, Sato S. Muroi E, et al. Among authors: fujimoto m. J Rheumatol. 2008 May;35(5):834-8. Epub 2008 Mar 1. J Rheumatol. 2008. PMID: 18322986

2

CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse.

Saito E, Fujimoto M, Hasegawa M, Komura K, Hamaguchi Y, Kaburagi Y, Nagaoka T, Takehara K, Tedder TF, Sato S. Saito E, et al. Among authors: fujimoto m. J Clin Invest. 2002 Jun;109(11):1453-62. doi: 10.1172/JCI15078. J Clin Invest. 2002. PMID: 12045259 Free PMC article.

3

Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis.

Sato S, Hayakawa I, Hasegawa M, Fujimoto M, Takehara K. Sato S, et al. Among authors: fujimoto m. J Invest Dermatol. 2003 Apr;120(4):542-7. doi: 10.1046/j.1523-1747.2003.12097.x. J Invest Dermatol. 2003. PMID: 12648215 Free article.

4

Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-alpha are elevated in patients with systemic sclerosis.

Furuse S, Fujii H, Kaburagi Y, Fujimoto M, Hasegawa M, Takehara K, Sato S. Furuse S, et al. Among authors: fujimoto m. J Rheumatol. 2003 Jul;30(7):1524-8. J Rheumatol. 2003. PMID: 12858452

5

Serum levels of tumor necrosis factor and interleukin-13 are elevated in patients with localized scleroderma.

Hasegawa M, Sato S, Nagaoka T, Fujimoto M, Takehara K. Hasegawa M, et al. Among authors: fujimoto m. Dermatology. 2003;207(2):141-7. doi: 10.1159/000071783. Dermatology. 2003. PMID: 12920362

6

Elevated circulating CD40L concentrations in patients with systemic sclerosis.

Komura K, Sato S, Hasegawa M, Fujimoto M, Takehara K. Komura K, et al. Among authors: fujimoto m. J Rheumatol. 2004 Mar;31(3):514-9. J Rheumatol. 2004. PMID: 14994397

7

Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells.

Sato S, Fujimoto M, Hasegawa M, Takehara K. Sato S, et al. Among authors: fujimoto m. Arthritis Rheum. 2004 Jun;50(6):1918-27. doi: 10.1002/art.20274. Arthritis Rheum. 2004. PMID: 15188368 Free article.

8

B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse.

Asano N, Fujimoto M, Yazawa N, Shirasawa S, Hasegawa M, Okochi H, Tamaki K, Tedder TF, Sato S. Asano N, et al. Among authors: fujimoto m. Am J Pathol. 2004 Aug;165(2):641-50. doi: 10.1016/S0002-9440(10)63328-7. Am J Pathol. 2004. PMID: 15277237 Free PMC article.

9

Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis.

Sato S, Fujimoto M, Hasegawa M, Takehara K, Tedder TF. Sato S, et al. Among authors: fujimoto m. Mol Immunol. 2004 Nov;41(12):1123-33. doi: 10.1016/j.molimm.2004.06.025. Mol Immunol. 2004. PMID: 15482848 Review.

10

The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system.

Tedder TF, Poe JC, Fujimoto M, Haas KM, Sato S. Tedder TF, et al. Among authors: fujimoto m. Curr Dir Autoimmun. 2005;8:55-90. doi: 10.1159/000082087. Curr Dir Autoimmun. 2005. PMID: 15564717 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,526 results

Search Page

Filters